{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:15:11Z","timestamp":1792800911886,"version":"4.5.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15881","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:54:52Z","timestamp":1790160892000},"page":"1-7","source":"Crossref","is-referenced-by-count":1,"title":["Therapy\u2011related acute myeloid leukemia with a rare complex karyotype following first\u2011line therapy for small cell lung cancer: A case report"],"prefix":"10.3892","volume":"32","author":[{"given":"Lin","family":"Luo","sequence":"first","affiliation":[{"name":"Clinical Laboratory, Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Yu","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"key20261020093301_b1-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"114248","DOI":"10.1016\/j.biopha.2023.114248","article-title":"Targeting the notch signaling pathway and the notch ligand, DLL3, in small cell lung cancer","volume":"159","author":"Zhang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"key20261020093301_b2-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1007\/s12672-025-03895-0","article-title":"Efficacy and safety of anlotinib maintenance therapy in limited-stage small cell lung cancer","volume":"16","author":"Li","year":"2025","journal-title":"Discov Oncol"},{"key":"key20261020093301_b3-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12885-024-12117-9","article-title":"Real-life clinical management patterns in extensive-stage small cell lung cancer across France: A multi-method study","volume":"24","author":"Mennecier","year":"2024","journal-title":"BMC Cancer"},{"key":"key20261020093301_b4-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"e25180","DOI":"10.1097\/MD.0000000000025180","article-title":"Comparison of atezolizumab, durvalumab, pembrolizumab, and nivolumab as first-line treatment in patients with extensive-stage small cell lung cancer: A systematic review and network meta-analysis","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"key20261020093301_b5-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jare.2023.12.020","article-title":"HMGB1 promotes chemoresistance in small cell lung cancer by inducing PARP1-related nucleophagy","volume":"66","author":"Shen","year":"2024","journal-title":"J Adv Res"},{"key":"key20261020093301_b6-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2025.0560","article-title":"Small cell lung cancer: A review","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"key20261020093301_b7-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/cancers12051081","article-title":"Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cancer"},{"key":"key20261020093301_b8-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"103607","DOI":"10.1016\/j.critrevonc.2022.103607","article-title":"Diagnosis and treatment of therapy-related acute myeloid leukemia","volume":"171","author":"Strickland","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20261020093301_b9-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-021-01119-w","article-title":"Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk\/secondary AML","volume":"14","author":"Cortes","year":"2021","journal-title":"J Hematol Oncol"},{"key":"key20261020093301_b10-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cbi.2009.11.025","article-title":"Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia","volume":"184","author":"Qian","year":"2010","journal-title":"Chem Biol Interact"},{"key":"key20261020093301_b11-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.seminhematol.2024.09.004","article-title":"Therapy-related myelodysplastic syndromes and acute myeloid leukemia","volume":"61","author":"Venugopal","year":"2024","journal-title":"Semin Hematol"},{"key":"key20261020093301_b12-ol-32-5-15881","first-page":"205","article-title":"Secondary neoplasm in survivors of childhood hematological malignancies-systematic review","volume":"13","author":"Horne\u021b","year":"2026","journal-title":"Children (Basel)"},{"key":"key20261020093301_b13-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/medicina58010048","article-title":"Very early onset of therapy-related acute myeloid leukemia with 11q23 rearrangement presenting with unusual PET findings after R-DA-EPOCH for primary mediastinal large B-cell lymphoma","volume":"58","author":"Chatzidimitriou","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"key20261020093301_b14-ol-32-5-15881","first-page":"1165","article-title":"Introduction and interpretation of the updated contents of the International System for Human Cytogenomic Nomenclature","volume":"38","author":"Wang","year":"2021","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"key20261020093301_b15-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-024-02115-5","article-title":"A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093301_b16-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ccr3.1931","article-title":"Therapy-related acute myeloid leukemia after chemotherapy in extensive disease-small cell lung cancer","volume":"7","author":"Ueda","year":"2019","journal-title":"Clin Case Rep"},{"key":"key20261020093301_b17-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"eado4618","DOI":"10.1126\/sciadv.ado4618","article-title":"ATR inhibition activates cancer cell cGAS\/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer","volume":"10","author":"Taniguchi","year":"2024","journal-title":"Sci Adv"},{"key":"key20261020093301_b18-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13039-019-0454-0","article-title":"Rare cytogenetic abnormalities and their clinical relevance in pediatric acute leukemia of Saudi Arabian population","volume":"12","author":"Alkhayat","year":"2019","journal-title":"Mol Cytogenet"},{"key":"key20261020093301_b19-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cancergencyto.2003.07.002","article-title":"A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia","volume":"149","author":"Potenza","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"key20261020093301_b20-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0165-4608(02)00642-8","article-title":"Generation of the NUP98-TOP1 fusion transcript by the t(11;20) (p15;q11) in a case of acute monocytic leukemia","volume":"140","author":"Chen","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"key20261020093301_b21-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/gcc.10239","article-title":"Both NUP98\/TOP1 and TOP1\/NUP98 transcripts are detected in a de novo AML with t(11;20)(p15;q11)","volume":"38","author":"Iwase","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"key20261020093301_b22-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10555-023-10159-2","article-title":"HOXA9 transcription factor is a double-edged sword: From development to cancer progression","volume":"43","author":"Shenoy","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"key20261020093301_b23-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.leukres.2013.09.013","article-title":"The fusion partner specifies the oncogenic potential of NUP98 fusion proteins","volume":"37","author":"Saw","year":"2013","journal-title":"Leuk Res"},{"key":"key20261020093301_b24-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/s41591-024-02992-x","article-title":"Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: Exploratory biomarker analysis of the randomized, phase 2 DESTINY-gastric01 trial","volume":"30","author":"Shitara","year":"2024","journal-title":"Nat Med"},{"key":"key20261020093301_b25-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ccell.2016.10.019","article-title":"NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis","volume":"30","author":"Xu","year":"2016","journal-title":"Cancer Cell"},{"key":"key20261020093301_b26-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3324\/haematol.2020.269944","article-title":"Reversible switching of leukemic cells to a drug-resistant, stem-like subset via IL-4-mediated cross-talk with mesenchymal stroma","volume":"107","author":"Lee","year":"2022","journal-title":"Haematologica"},{"key":"key20261020093301_b27-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.3390\/ijms23179824","article-title":"Recurrent translocations in topoisomerase inhibitor-related leukemia are determined by the features of DNA breaks rather than by the proximity of the translocating genes","volume":"23","author":"Lomov","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20261020093301_b28-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/cancers15061658","article-title":"Progress toward better treatment of therapy-related AML","volume":"15","author":"Kotsiafti","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20261020093301_b29-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/pharmaceutics13030365","article-title":"Tumor activated cell penetrating peptides to selectively deliver immune modulatory drugs","volume":"13","author":"Hingorani","year":"2021","journal-title":"Pharmaceutics"},{"key":"key20261020093301_b30-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"108409","DOI":"10.1016\/j.mrrev.2021.108409","article-title":"DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol","volume":"789","author":"Tang","year":"2022","journal-title":"Mutat Res Rev Mutat Res"},{"key":"key20261020093301_b31-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"E125","DOI":"10.1002\/ajh.23744","article-title":"The relation between cigarette smoking and risk of acute myeloid leukemia: An updated meta-analysis of epidemiological studies","volume":"89","author":"Fircanis","year":"2014","journal-title":"Am J Hematol"},{"key":"key20261020093301_b32-ol-32-5-15881","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1182\/bloodadvances.2023010111","article-title":"Cigarette smoke exposure accelerates AML progression in FLT3-ITD models","volume":"7","author":"Figueroa","year":"2023","journal-title":"Blood Adv"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:33:06Z","timestamp":1792477986000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,23]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15881","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}